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Abstract
Background: Patients may find it difficult to distinguish between the symptoms of anxiety and
those of asthma. Findings are equivocal on whether there is a specific link between anxiety and
asthma. The aims of this study were to i) to identify the prevalence of anxiety, depression and panic
fear in adults with asthma compared with that of the general population ii) to investigate whether
there is a specific relationship between asthma and anxiety.
Methods: An epidemiological survey of 872 adults with a diagnosis of asthma identified from six
General Practices in Sheffield, England. Community postal survey using self-completion
questionnaire.
Results: The response rate was 59%. People with asthma had higher mean Hospital Anxiety and
Depression Scale (HADS) anxiety scores than UK norms with a higher proportion above the
clinical cut-off. Mean HADS depression scores were significantly higher than UK norms and norms
for a general population sample of people registered with the same practice. These effects were
age-related with the relationship between asthma and psychological distress most marked over the
age of 45. The prevalence of asthma-specific panic fear was 15.7%.
Conclusion: A significant minority of people have high levels of panic fear (as measured by the
Asthma Symptom Checklist) associated with asthma. However, in adults with asthma there is also
high prevalence of both generalised anxiety and depression (as measured by the HADS), suggesting
that the link of anxiety to asthma may be part of a broader relationship between psychological
distress and chronic disease rather than a specific one.
Background
There has been considerable research on the relationship
between asthma and anxiety. Recent reviews [1-3] of the
literature describe an increased rate of psychological co-
morbidity in adults with asthma including anxiety and
panic symptoms. Although anxiety is a normal reaction to
extreme dyspnea [4], and may even be functional in mod-
eration [5,6], high levels of panic fear may lead both to
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exacerbation of the condition and poor management. For
example, it has been demonstrated that panic may trigger
an asthma attack through hyperventilation and airways
cooling [7]. Patients may find it difficult to distinguish
between the symptoms of anxiety and those of asthma
leading to inappropriate self-medication [8]. A New Zea-
land study of management errors in acute severe asthma
in adults found that most were related to patient behav-
iour, and that panic and the overuse of beta-agonists were
important contributory causes [9]. In a study of the
Asthma Symptom Checklist [10] used in people with
asthma recruited from general practice, the responses to
the panic fear subscale predicted oral steroid intake and
the authors concluded that the emotional impact of
asthma showed a stronger association with aspects of
asthma management than symptoms of dyspnea did.
Similarly, anxiety has been shown to be related levels of
oral corticosteroid prescribing in near-fatal asthma
patients [11].
Findings are equivocal on whether there is a specific link
between panic and respiratory disorders including
asthma. The high prevalence of panic-fear or anxiety
symptoms in asthma populations does not in itself estab-
lish a specific link as this could be part of a broader rela-
tionship between any chronic disease and lowered
psychological wellbeing. A Swedish research group found
significant correlation of anxiety and depression with self-
reported respiratory symptoms, but not objective asthma
variables using the Hospital Anxiety and Depression Scale
[12]. This finding was replicated in asthma patients
treated in GP practices in the UK, where there were signif-
icant correlations of HADS anxiety and depression with
self-reported symptoms from the Asthma Quality of Life
Questionnaire, but not with objective measures of lung
function [13]. A recent review [14] of the literature
reported that the findings are inconclusive on whether
people with asthma are more likely to be depressed than
those without asthma. Although HADS anxiety has been
estimated in community samples of adults with asthma,
ASC panic fear, a measure of asthma specific anxiety, has
previously been less frequently reported in community
populations. The higher rates of panic in hospital attend-
ees could be a selection bias of hospital attendance, in that
these rates may be associated with attendance at hospital.
This paper addresses the question of whether the higher
levels of anxiety demonstrated in people with asthma is
specifically linked or whether it is part of a picture of
reduced psychological well-being by exploring the preva-
lence, in adults with asthma, of anxiety and panic fear as
well as the prevalence of depression which has not previ-
ously been conclusively established.
Research questions
1. What is the prevalence of anxiety, panic fear and depres-
sion in adults with asthma, irrespective of their consulta-
tion history?
2. Is this prevalence significantly higher than that found in
a general population survey of health and illness in the
same General Practices and with UK normative data?
3. Are anxiety scores rather than depression scores ele-
vated, compared with the general population, to support
the suggestion of a specific relationship between asthma
and anxiety?
4. Does the comparison of anxiety and panic fear levels
with those in clinic-based samples suggest a selection bias
of hospital attendance in previous research?
Throughout this paper levels of anxiety, panic fear and
depression are reported as assessed using generally agreed
cut-off points on established measures (HADS and ASC)
and not as clinically diagnosed psychological disorders.
Methods
A random sample of 872 adults with asthma was obtained
from six General Practices (serving a population of 32,343
listed permanent adult patients) in Sheffield, England
during 1998 and 1999. Practices were selected to repre-
sent a wide range of Townsend deprivation scores (from
4.9 to -2.6). The six practices had a total of 2169 adult
patients between the ages of 18 and 65 with a diagnosis of
asthma registered with them. A random sample of 872
(approximately 40% of registered adults with asthma)
was identified using computer generated random num-
bers. Each patient received a letter from the GP inviting
him or her to complete and return an enclosed question-
naire.
The questionnaire included demographic questions, and
a screening tool comprising the Asthma Symptom Check-
list (ASC) and the Hospital Anxiety and Depression Scale
(HADS).
The ASC [15] is a self-report questionnaire widely used in
asthma research to assess subjective asthma symptomatol-
ogy including panic-fear. It was derived from empirical
cluster analysis in a hospital sample, replicated in a later
study [15,16] and has been validated in the UK [17]. We
used a nine item version of ASC panic fear with response
options of 1 to 5 and a cut off score of 28 and above. The
cut off was derived from conventional practice of consid-
ering an average item score of 3 or more to be in the clin-
ical range [16]. A more recent reevaluation of the ASC
demonstrated that, although some of the items included
in the panic fear scale may be redundant, the original fiveBMC Family Practice 2007, 8:62 http://www.biomedcentral.com/1471-2296/8/62
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factors, including one representing panic-fear, were repli-
cated and the internal consistency of the panic fear scale
was good [10].
The HADS is a brief (14 item) scale developed as a relia-
ble, practical and valid tool for identifying and quantify-
ing anxiety and depression in patients in hospital clinics
[18]. It has been extensively used in hospital and primary
care patients and in the general population and reviews of
its use confirm its value as a case finder for anxiety disor-
ders and depression in these populations [19,20]. The
internal consistency of the HADS has been well demon-
strated and optimal balance between sensitivity and spe-
cificity for HADS as a screening tool is achieved using a
cut-off of 8+ for both HAD anxiety and depression sub-
scales [20].
Strategies for increasing the response rate to postal ques-
tionnaires were employed [21] including sending two
reminders to non-respondents.
Ethical approval for this study was obtained from both
North and South Sheffield Local Research Ethics Commit-
tees.
Comparison data
HADS anxiety and depression scores were compared with
Crawford's community sample of 1792 UK adults [22]. In
Crawfords study HADS data were collected from 1792
members of the general adult population (females = 978,
males = 810). Participants were recruited from a wide vari-
ety of sources including commercial and public service
organizations, community centres and recreational clubs.
The mean age of the sample was 41.5 years (SD = 15.9,
range = 18–91). Each potential participant received an
introductory letter, a HADS form and a form for recording
demographic variables. The refusal rate was approxi-
mately 18%.
HADS depression scores were also compared with those
of patients from the same General Practices, a subset of
the Sheffield Health and Illness Survey (SHAIPS) [23].
SHAIPS was a postal survey of a representative sample of
the population of Sheffield looking at health status and
use of health services and included the HADS depression
scale. It was carried out two years after the survey reported
here. The sampling frame used was the local population
health register which contains, amongst other data, the
GP with whom the person is registered. Stratification was
used to ensure that the sample was representative of the
Sheffield population in terms of age, sex and electoral
ward. It is likely that some individuals responded to both
surveys but the number doing so is unknown.
Data analysis
Data analysis was undertaken using SPSS software (ver-
sion 10). The chi2 test was used to compare proportions of
clinically significant scores for HADS and ASC measures
between men and women, chi2 for trend for differences by
age group, and Spearman's rank correlation was used to
determine any relationship between continuous age and
HADS/ASC score. Analysis of variance was used to com-
pare HADS anxiety and depression scores with data from
the UK and the general population of Sheffield. t-tests
were used for comparison of means. Ideally, multiple
regression analysis would have been used to determine
whether there were differences in HADS depression by age
and sex between the study population and the general
population of Sheffield. However, as we did not have
access to the SHAIPs raw data we undertook individual t-
tests on each age, sex combination.
Data oversight
The investigators who collected and analysed the data
reported to, and were advised by, a data monitoring group
independent of the researchers.
Results
Respondents
461 completed questionnaires were received giving a
crude response rate of 53%. After accounting for 89 ques-
tionnaires returned either undelivered or marked indicat-
ing that the recipient did not have asthma the adjusted
response rate was 59%.
We had a higher proportion of responses from women –
38.3% of respondents were male and 61.7% female. This
approximately reflects the sex distribution of the Sheffield
population and a higher prevalence of asthma in women
in Sheffield [23].
The mean age of respondents was 42.4 (S.D = 13.4) years,
the median was 41 years and the range was 18–66 years.
The % of respondents in each age group approximately
reflects the age distribution of the Sheffield population
except for a slightly lower response rate in the younger age
group [24].
HADS anxiety
The proportion of patients with a HADS anxiety score of
10 or more was 31.6%. HADS anxiety score increased with
age for both scores 8+ (chi2 = 10.602, p = 0.031) and 10+
(chi2 = 21.218, p < 0.001). There was no significant differ-
ence between men and women with respect to these pro-
portions. However, there was a significant difference in
mean HADS anxiety scores by sex (Mann-Whitney U = -
2.916, p = 0.004). Women had a mean score of 8.2 (S.D =
4.5) compared with a mean score of 6.9 (S.D. = 4.3) for
men. The proportion of people with asthma with anxietyBMC Family Practice 2007, 8:62 http://www.biomedcentral.com/1471-2296/8/62
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at a level of possible clinical disorder (HADS anxiety score
8–10) is no different from the general population. How-
ever, the proportion with probable clinical disorder (scor-
ing 11+), is double that in the general population. The cut
off of 11+ is used here for direct comparison with UK nor-
mative data22. Mean HADS anxiety scores were also signif-
icantly higher for the asthma sample, compared with UK
norms (Table 1).
HADS depression
The proportion of patients with a HADS depression score
of 10 or more was 13.6%. HADS depression score
increased with age for both scores 8+ (chi2 = 47.988, p <
0.001) and 10+ (chi2 = 30.721, p < 0.001). There were no
significant differences between men and women.
Mean HADS depression scores were significantly higher
for the asthma sample, compared with UK norms (Table
2). The proportion of the asthma population with depres-
sion at levels of both possible and probable clinical disor-
der was significantly greater than UK normative data
(Table 2).
Mean HADS depression scores were also significantly
higher for the respondents of our survey compared with
Sheffield general population data, for the total sample,
and for men and women separately (Table 3). This effect
was accounted for by the older age groups (45–54 years
and 55–64 years): see Table 3.
The proportion of the asthma population sample with
high HADS depression scores was significantly higher for
all categories:- 8+ and 11+ (Table 4).
Asthma specific panic fear
The prevalence of asthma-specific anxiety from the ASC
Panic Fear score was 15.7% (62/395). Women were signif-
icantly more likely than men to experience panic fear
associated with asthma: 19.2% (46/239) compared with
10.6% (16/151, Mann-Whitney U = -2.498, p < 0.05). The
mean panic-fear ASC score (S.D.) was 17.9 (8.5) overall
and 16.7 (8.3) for men compared with 18.7 (8.7) for
women. The range was 9 – 44. The mean score for women
was significantly higher than that for men (Mann-Whit-
ney U = -2.498, p = 0.012). There was a significant corre-
lation between increase in ASC score and increased in age
(r = 0.114, p < 0.05).
Discussion and conclusion
Summary of main findings
The results of this study clearly show that both the preva-
lence of anxiety and the level of anxiety experienced by
people with asthma (as measured using the HADS) are
higher than that of the general population. Almost one
third of asthma sufferers experience anxiety at the level of
probable clinical disorder, double that in the general pop-
ulation. The prevalence of anxiety is higher in women
than in men with asthma and increases with age. A signif-
icant minority of people with asthma experience asthma
specific anxiety as measured by the panic fear subscale of
the Asthma Symptom Checklist. However, the fact that
the prevalence of generalised anxiety and depression are
high in this population indicates that anxiety experienced
in asthma may be part of a broader picture of generalised
psychological distress rather than indicating that panic
has a specific role in asthma.
Comparison with existing literature
These results from a general population sample are
important in that they support the evidence of panic
reported previously for hospital attenders [11,25], dem-
onstrating that the findings are not only seen in hospital
attenders but generally for people with asthma. Our find-
ings are consistent with those reported previously. Rim-
ington [13] found that 30% of patients with a diagnosis of
asthma recruited through general practice had anxiety
scores of 11 or more on the HADS suggestive of a clinical
anxiety state, for inner city patients this rate was 40%. In
the same study 10% of patients had HADS scores suggest-
ing depression with mean scores (S.D) of 3.7 (2.7) and
6.0 (4.3) for suburban and inner city patients respectively
compared with our findings of a mean HADS depression
score of 4.72 (4.08). An Australian study [26] reported a
prevalence of anxiety (scoring 8 or more on HADS) of
Table 1: Hospital Anxiety and Depression Scale anxiety: Comparison of asthma population survey data with population norms [22]
Asthma Population Population norm 
(Crawford et al)
Difference 95% CI p-value
n4 5 5 1 7 9 2
Median 7.0 6.0
Mean (sd) 7.79 (4.45) 6.14 (3.76) +1.65 +1.23 to +2.05 <0.001
% score 8+ 47.3% 33.2% +0.14.1% +9.0 to +19.1%
% score 8–10 20.9% 20.6% +0.3% 3.7 to +4.7%
% score 11–15 20.2% 10.0% +10.2% +6.5 to +14.4%
% score 16+ 5.9% 2.6% +3.3% +1.3 to +6.0%BMC Family Practice 2007, 8:62 http://www.biomedcentral.com/1471-2296/8/62
Page 5 of 7
(page number not for citation purposes)
40% of patients with asthma. More-over the findings add
weight to the evidence supporting increased levels of
depression in asthma [14].
The results also corroborate the general findings of high
levels of panic experienced by people with asthma
reported in a recent review [1]. Specific comparison of our
results with other published studies is not straightforward
as variations of the ASC panic fear subscale are used. The
ASC mean scores reported in this paper are some-what
higher than those reported for a comparable study [10] of
asthma patients recruited from General Practice but the
significantly higher levels in women compared with men
is replicated.
That higher levels of anxiety and depression are associated
with increasing age in the asthma population is interest-
ing. In other chronic conditions psychological distress has
been shown to decrease with age [27], as it does in the
general population [28]. The present findings may be
explained by evidence that the level of depression experi-
enced in asthma is related to the level of illness uncer-
tainty [29]. It may be that older people may feel more
uncertain about managing their asthma. An alternative
explanation may be that psychological distress increases
with increasing duration of asthma as reported previously
in men [30]. However, the upper age limit in this study
was 65 years so the older age group were somewhat
younger than comparable studies [27].
Strengths and limitations of this study
In the present study, duration of illness was not recorded
so that it is not possible to distinguish between associa-
tion of asthma with age or duration of illness. It is also
likely that a proportion of participants may have had
Chronic Obstructive Pulmonary Disease which occurs
from around 45+ years and has been shown to have a
major impact on QOL and mood [31]. This may explain
the link between depression and age. In this study the GP
diagnosis of asthma was not verified though the upper age
limit was restricted to 65 as the likelihood of COPD
increases significantly over 65 years.
A limitation of the study is that the sample was drawn
from one UK city. Comparisons were made with data
from the general population from the same GP practices
indicating that the findings of psychological distress are
related to the experience of asthma or chronic disease
rather than being related to the specific location. How-
ever, a recent, comparable, community study reported a
prevalence of 'possible' anxiety of 38% and 'probable'
anxiety of 18.9% in people with asthma and prevalence
levels of depression were no greater than controls [32].
This was carried out in a relatively affluent rural, mainly
Caucasian population, indicating that prevalence of psy-
chological distress associated with asthma may vary with
geographical and socioeconomic factors. An earlier study
reported significant differences in the level of anxiety and
depression experienced by people with asthma living in a
suburban compared with an inner city location [13].
Table 3: Mean Hospital Anxiety and Depression Scale depression 
score: Comparison of asthma population survey data with 
Sheffield Health and Illness Prevalence Survey (SHAIPS) findings 
for the same six practices
Total Males Females
All ages Asthma 4.70 4.64 4.72
SHAIPS (6 practices) 3.58 3.62 3.55
p-value <0.001 <0.01 <0.001
18–34 Asthma 3.34 3.33 3.36
SHAIPS (6 practices) 3.02 2.73 3.23
p-value = 0.298 = 0.212 = 0.763
35–44 Asthma 3.39 2.92 3.73
SHAIPS (6 practices) 3.45 3.38 3.51
p-value = 0.882 = 0.498 = 0.708
45–54 Asthma 6.24 6.66 6.02
SHAIPS (6 practices) 4.18 4.60 3.85
p-value <0.001 = 0.025 <0.001
55–64 Asthma 6.44 6.97 6.12
SHAIPS (6 practices) 4.21 4.48 3.97
p-value <0.001 <0.001 <0.01
Table 2: Hospital Anxiety and Depression Scale depression: Comparison of asthma population survey data with population norms 
[22]
Asthma population Population norm 
(Crawford et al)
Difference 95% CI p-value
n 454 1792
Median 4.0 3.0
Mean (sd) 4.72 (4.08) 3.68 (3.07) +1.04 +0.67 to +1.42 <0.001
% score 8+ 22.3% 11.4% +10.9% +7.0 to +15.1%
% score 8–10 13.0% 7.8% +5.2% +2.1 to +8.8%
% score 11–15 7.9% 2.9% 5.0% +2.7 to +8.0%
% score 16+ 1.3% 0.7% +0.6% -0.3 to 2.2%BMC Family Practice 2007, 8:62 http://www.biomedcentral.com/1471-2296/8/62
Page 6 of 7
(page number not for citation purposes)
A further limitation is that no attempt was made to assess
the prevalence of clinically diagnosed anxiety, depression
or panic fear in the population.
A strength of this study is the relatively large sample size,
however it is acknowledged that lack of information
related to possible non-response bias is a weakness. Care
was also taken to ensure that the socio-economic demo-
graphics of the practice populations reflected that of the
city as a whole.
Implications for future research and clinical practice
In our parallel study [33] into the management of anxiety
in asthma, GPs had difficulties identifying clinically anx-
ious patients. This indicates that anxiety related complica-
tions of asthma might not be recognised in general
practice despite high prevalence levels. The screening tool
used in this study could be used in both general practice
and hospital clinics to identify patients with asthma expe-
riencing levels of anxiety that may affect their ability to
manage their asthma. Once such patients are identified,
providing effective interventions to meet their psycholog-
ical needs may pose a challenge to community services.
Further research is needed into effectiveness of interven-
tions to help people with asthma manage the associated
psychological distress, particularly interventions which
can be delivered by those staff already in contact with
patients such as the asthma clinic nurse.
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